淫羊藿苷和仙茅苷协同抑制破骨细胞的形成、分化和骨吸收功能

郭元晖; 薛黎明; 聂燕; 汪滢; 赵璐; 秦路平; 张巧艳; 俞媛

doi:10.3969/j.issn.1006-0111.2013.04.006

淫羊藿苷和仙茅苷协同抑制破骨细胞的形成、分化和骨吸收功能

doi: 10.3969/j.issn.1006-0111.2013.04.006

1.
第二军医大学药学院, 上海 200433
2.
福建中医药大学药学院, 福建福州 350108

基金项目: 国家自然科学基金项目(81173191);第二军医大学大学生创新基金项目(ZD2010024).

Effect of icariin and curculigoside on inhibition of osteoclastic formation, differentiation and bone absorption

1.
School of Pharmacy, Second Military Medical University, Shanghai 200433, China
2.
Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, China

摘要: 目的研究淫羊藿苷和仙茅苷配伍抑制破骨细胞形成、分化和骨吸收的相互作用关系。方法用1, 25-(OH)₂Vitamin D₃和地塞米松;或人巨噬细胞集落刺激因子(MCSF)和核因子κ B受体活化因子配体(RANKL)诱导骨髓单核细胞使其分化为破骨细胞抗酒石酸酸性磷酸酶(TRAP)染色进行阳性破骨细胞鉴定;磷酸苯二钠法测定抗酒石酸酸性磷酸酶活性;将破骨细胞和骨片共同培养,以计算机图像分析测定骨吸收陷窝的面积;以Hoechst 33258和罗丹明-鬼笔环肽染色,激光共聚焦显微镜观察破骨细胞肌动蛋白环(F-actin Ring)的形态;用Western-blot分析细胞骨架相关蛋白的表达。结果淫羊藿苷和仙茅苷在1×10^-6mol/L浓度下可协同抑制破骨细胞的形成、降低抗酒石酸酸性磷酸酶的活性,减少破骨细胞在骨片上形成的骨吸收陷窝面积,抑制破骨细胞骨架F-actin环的构建及其调控因子Rho GTPases 和灶性黏附激酶(focal adhesion kinase, FAK)的表达。结论淫羊藿苷和仙茅苷协同抑制破骨细胞性的骨吸收,为药对淫羊藿仙茅的配伍提供了实验依据。
- 淫羊藿苷 /
- 仙茅苷 /
- 破骨细胞 /
- 细胞骨架 /
- 协同作用
Abstract: Objective To investigate the interaction relationship of icariin and curculigoside on the osteoclastic formation, differentiation and bone resorbing. Methods Multinucleated osteoclasts were induced by 1, 25-dihydroxyvitamine D₃ and dexamethasone from bone marrow cells with the presence of primary osteoblastic cells, or induced with RANKL and MCSF.The activity of TRAP was measured by p-nitrophenyl sodium phosphate assay.The bone absorption pit area on the bone slices formed by osteoclast was measured by computer image processing.The F-actin ring were stained with Hoechst 33 258 and rhodamine-phalloidin, and then observed under the confocal scanning laser microscopy. The Western-blot was used to analysis the expression of protein which was related to the cytoskeleton of osteoclasts. Results Icariin and curculigoside at the concentration of 1×10^-6mol/L synergistically inhibited the osteoclastic formation, decreased the activity of TRAP, and reduced the area of bone resorption pit on bone slices, inhibited the organization of F-actin ring and the expression of FAK and Rho GTPases. Conclusions Icariin and curculigoside synergistically inhibited the osteoclastic bone resorption, which provided scientific basis for the theory of the compatibility of traditional Chinese medicine Epimedii Folium and CurculiginIs Rhizoma.
- icariin /
- curculigoside /
- osteoclasts /
- cytoskeleton /
- synergism

[1]	林殷, 郭华, 林毅,等. 命门用药之特点初探(三)[J]. 北京中医药大学学报,2008,31(5):303.
[2]	徐忠明,周志昆. 黄芪三仙汤对绝经后妇女骨密度和骨矿含量指标影响的研究[J]. 深圳中西医结合杂志,2009, 19(2):84.
[3]	沈自尹. 淫羊藿总黄酮对应一个药靶的探索过程[J] 中药新药与临床药理. 2003,14(5):293.
[4]	Jiao L, Cao DP, Qin LP, et al. Antiosteoporotic activity of phenolic compounds from Curculigo orchioide[J]. Phytomedicine, 2009, 16:874.
[5]	刘祖德,臧鸿声,欧阳跃平.新生大鼠颅骨成骨性细胞体外生长过程研究[J].解剖学报,1995, 26(2):157.
[6]	Li B,Yu S.Genistein prevents bone resorption diseases by inhibiting bone resorption and stimulating bone formation[J].Biol Pharm Bull,2003, 26(6):780.
[7]	Zhang Q,Qin L,He W,et al.Coumarins from Cnidium monnieri and their antiosteoporotic activity[J].Planta Med,2007, 73(1):13.
[8]	鲍蕾蕾,秦路平,卞俊,等. 巴戟天甲基异茜草素对破骨细胞性骨吸收的影响[J]. 解放军药学学报, 2009,25(6):508.
[9]	Stavros CM.Birth and death of bone cells:Basic regulatory mechanism and implications for the pathogenesis and treatment of osteoporosis[J].Endocrine Reviews,2000,21(2):115.
[10]	Mitra SK, Hanson DA,Schlaepfer DD.Focal adhesion kinase:in command and control of cell motility[J].Nat Rev Mol Cell Biol,2005,6:56.
[11]	Ory S, Brazier H, Pawlak G, et al. Rho GTPases in osteoclast:Orchestrators of podosome arrangement[J].Eur J Cell Biol,2008,87:469.
[12]	姚志红. Rho GTPase在信号转导和细胞骨架中的作用[J].国际病理科学与临床杂志,2009,29(1):20.
[13]	Zhang Z,Neff L,Bothwell ALM,et al.Calcitonin induces dephosphorylation of pyk2 and phosphorylation of focal adhesion kinase in osteoclasts[J].Bone,2002,31(3):359.
[14]	Xiong WC, Feng X. Pyk2 and FAK in osteoclasts[J]. Frontiers in Bioscience, 2003, 8:1219.

[1]	李娜, 黄诚文, 孙秀娟, 王晓红, 张丽, 王兴坡. 奥希替尼与吉非替尼治疗表皮生长因子受体突变的晚期非小细胞肺癌的成本效果分析 . 药学实践与服务, 2025, 43(12): 608-613. doi: 10.12206/j.issn.2097-2024.202411032
[2]	曹奇, 张嘉宝, 王培. 基于无监督自动降维分析与手动圈门联用的骨骼肌髓系细胞多色流式分析方法 . 药学实践与服务, 2025, 43(7): 325-328, 366. doi: 10.12206/j.issn.2097-2024.202404077
[3]	迟文雅, 袁艳, 李伟林, 吴茼妤, 俞媛. 负载骨髓间充质干细胞/白藜芦醇脂质体的水凝胶支架治疗创伤性脑损伤的研究 . 药学实践与服务, 2025, 43(2): 67-74. doi: 10.12206/j.issn.2097-2024.202406034
[4]	杨志晖, 蔡华丹, 徐方楚, 刘园, 袁海龙. 临床药师参与人粒细胞刺激因子致弥漫性肺泡出血的病例分析 . 药学实践与服务, 2025, 43(11): 567-571. doi: 10.12206/j.issn.2097-2024.202506021
[5]	孙波, 吕宗强, 罗宁, 李荣, 王洪祥, 陈菊祥. Angiopep-2修饰的细菌外囊泡载药系统治疗胶质母细胞瘤效果研究 . 药学实践与服务, 2025, 43(10): 481-490. doi: 10.12206/j.issn.2097-2024.202506017
[6]	赵全公, 王国坤, 徐志云. 虾青素通过激活Nrf2/HO-1通路抑制瓣膜间质细胞钙化 . 药学实践与服务, 2025, 43(6): 283-287. doi: 10.12206/j.issn.2097-2024.202412057
[7]	邵明聪, 陈虎博, 张懿丹, 李梓嫣, 王丽娜. 乌头煎剂对小鼠RAW264.7巨噬细胞活性和极化的影响 . 药学实践与服务, 2025, 43(7): 329-334. doi: 10.12206/j.issn.2097-2024.202505043
[8]	胡越, 殷勇, 徐晓红, 施柳辉, 朱建勇, 年华. 基于网络药理学探讨夏枯草消瘤合剂治疗非小细胞肺癌的作用机制 . 药学实践与服务, 2025, 43(12): 1-8. doi: 10.12206/j.issn.2097-2024.202302020
[9]	于翔, 贾培培, 李欣颖, 杨君君, 郭高峰, 陆连芳. M2型巨噬细胞外泌体喷剂对压力性损伤的疗效及作用机制 . 药学实践与服务, 2025, 43(9): 436-442. doi: 10.12206/j.issn.2097-2024.202503066
[10]	杨金润, 黎翔, 孙旸. ORM1促肝细胞增殖的作用及其机制探索 . 药学实践与服务, 2025, 43(5): 222-227. doi: 10.12206/j.issn.2097-2024.202410014
[11]	冯一帆, 严啸东, 张文彬, 李炳锋, 郭美丽. 菸花苷长期给药对脑缺血再灌注损伤大鼠神经功能的影响 . 药学实践与服务, 2025, 43(5): 228-234. doi: 10.12206/j.issn.2097-2024.202407038
[12]	乔方良, 蒋益萍, 夏天爽, 刘爱军, 赵凯, 辛海量. 对萼猕猴桃苷E提取分离纯化工艺的研究 . 药学实践与服务, 2025, 43(): 1-7. doi: 10.12206/j.issn.2097-2024.202407001
[13]	江冼芮, 段雅倩, 刘畅, 张成中. 淫羊藿中黄酮苷类化合物的群体感应抑制作用研究 . 药学实践与服务, 2025, 43(4): 169-173. doi: 10.12206/j.issn.2097-2024.202409060
[14]	刘丽艳, 余小翠, 孙传铎. 纳武利尤单抗治疗非小细胞肺癌有效性及安全性的Meta分析 . 药学实践与服务, 2024, 42(10): 451-456. doi: 10.12206/j.issn.2097-2024.202310044
[15]	宋雨桐, 夏德润, 顾珩, 唐少文, 易洪刚, 沃红梅. 帕博利珠单抗与铂类化疗方案在晚期非小细胞肺癌一线治疗中的药物经济学评价 . 药学实践与服务, 2024, 42(8): 334-340. doi: 10.12206/j.issn.2097-2024.202303023
[16]	冯志惠, 邓仪卿, 叶冰, 安培, 张宏, 张海军. 雀梅藤石油醚提取物诱导三阴性乳腺癌细胞凋亡的实验研究 . 药学实践与服务, 2024, 42(6): 253-259. doi: 10.12206/j.issn.2097-2024.202311055
[17]	修建平, 杨朝爱, 刘禧澳, 潘乾禹, 韦广旭, 王卫星. 全反式维甲酸对肝星状细胞活化及氧化应激的作用和机制探索 . 药学实践与服务, 2024, 42(7): 291-296. doi: 10.12206/j.issn.2097-2024.202312054
[18]	景凯, 杨慈荣, 张圳, 臧艺蓓, 刘霞. 黄芪甲苷衍生物治疗慢性心力衰竭小鼠的药效评价及作用机制研究 . 药学实践与服务, 2024, 42(5): 190-197. doi: 10.12206/j.issn.2097-2024.202310004
[19]	姜涛, 徐卫凡, 蒋益萍, 夏天爽, 辛海量. 巴戟天丸组方对Aβ损伤成骨细胞的作用及基于网络药理学的机制研究 . 药学实践与服务, 2024, 42(7): 285-290, 296. doi: 10.12206/j.issn.2097-2024.202305011
[20]	杨媛媛, 安晓强, 许佳捷, 江键, 梁媛媛. 正极性驻极体联合5-氟尿嘧啶对瘢痕成纤维细胞生长抑制的协同作用 . 药学实践与服务, 2024, 42(6): 244-247. doi: 10.12206/j.issn.2097-2024.202310027

点击查看大图

计量

文章访问数: 5298
HTML全文浏览量: 624
PDF下载量: 599
被引次数: 0

姓名
邮箱
手机号码
标题
留言内容
验证码

留言板

淫羊藿苷和仙茅苷协同抑制破骨细胞的形成、分化和骨吸收功能

doi: 10.3969/j.issn.1006-0111.2013.04.006

Effect of icariin and curculigoside on inhibition of osteoclastic formation, differentiation and bone absorption

计量

淫羊藿苷和仙茅苷协同抑制破骨细胞的形成、分化和骨吸收功能

doi: 10.3969/j.issn.1006-0111.2013.04.006

1. 第二军医大学药学院, 上海 200433

2. 福建中医药大学药学院, 福建福州 350108

English Abstract

Effect of icariin and curculigoside on inhibition of osteoclastic formation, differentiation and bone absorption

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, China

全文HTML

目录

留言板

淫羊藿苷和仙茅苷协同抑制破骨细胞的形成、分化和骨吸收功能

doi: 10.3969/j.issn.1006-0111.2013.04.006

Effect of icariin and curculigoside on inhibition of osteoclastic formation, differentiation and bone absorption

计量

出版历程

淫羊藿苷和仙茅苷协同抑制破骨细胞的形成、分化和骨吸收功能

doi: 10.3969/j.issn.1006-0111.2013.04.006

1. 第二军医大学药学院, 上海 200433 2. 福建中医药大学药学院, 福建 福州 350108

English Abstract

Effect of icariin and curculigoside on inhibition of osteoclastic formation, differentiation and bone absorption

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China 2. Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, China

全文HTML

目录

1. 第二军医大学药学院, 上海 200433

2. 福建中医药大学药学院, 福建福州 350108

1. School of Pharmacy, Second Military Medical University, Shanghai 200433, China

2. Department of Pharmacy, Fujian University of Traditional Chinese Medicine, Fuzhou 350108, China